Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Int J Cardiol

Retrieve available abstracts of 34 articles:
HTML format

Single Articles

    July 2024
  1. BOROVAC JA, D'Amario D, Miric D
    Management of dyslipidemia after atherosclerotic cardiovascular event: Still a long way to go...and we know it.
    Int J Cardiol. 2024;406:131967.

    May 2024
  2. HOE JK, Flege MM, Jimenez-Solem E, Hansen S, et al
    Monitoring and treatment of hypercholesterolemia after an atherosclerotic cardiovascular disease event in Denmark from 2015 to 2020.
    Int J Cardiol. 2024;402:131857.
    PubMed     Abstract available

    April 2024
  3. ORTEGA-PAZ L, Bonaca M, Angiolillo DJ
    Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies.
    Int J Cardiol. 2024;400:131803.

    March 2024
  4. PINGITORE A, Zhang C, Vassalle C, Ferragina P, et al
    Machine learning to identify a composite indicator to predict cardiac death in ischemic heart disease.
    Int J Cardiol. 2024 Mar 23:131981. doi: 10.1016/j.ijcard.2024.131981.
    PubMed     Abstract available

    February 2024
  5. KWAK S, Lee HJ, Lee H, Park JB, et al
    Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;396:131574.
    PubMed     Abstract available

    January 2024
  6. CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
    Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
    Int J Cardiol. 2024;395:131578.
    PubMed     Abstract available

    December 2023
  7. WU Y, Huang N, Sun T, Zhang B, et al
    Association between normalized lactate load and in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2023 Dec 23:131658. doi: 10.1016/j.ijcard.2023.131658.
    PubMed     Abstract available

    November 2023
  8. SOLNICA B, Sniderman AD, Wyszomirski A, Rutkowski M, et al
    Concordance/discordance between serum apolipoprotein B, low density lipoprotein cholesterol and non-high density lipoprotein cholesterol in NATPOL 2011 participants - An epidemiological perspective.
    Int J Cardiol. 2023;390:131150.
    PubMed     Abstract available

    August 2023
  9. GURGOGLIONE FL, Rizzello D, Giacalone R, Ferretti M, et al
    Precipitating factors in patients with spontaneous coronary artery dissection: Clinical, laboratoristic and prognostic implications.
    Int J Cardiol. 2023;385:1-7.
    PubMed     Abstract available

    May 2023
  10. SHADAREVIAN J, Zhu K, Kwan JM, Wan D, et al
    Arrhythmic and thromboembolic outcomes in adults with coarctation of the aorta.
    Int J Cardiol. 2023 May 29:S0167-5273(23)00741.
    PubMed     Abstract available

    February 2023
  11. D'ASCENZO F, Bruno F, Iannaccone M, Testa G, et al
    Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00256.
    PubMed     Abstract available

  12. WEINTRAUB WS, Mancini GBJ, Boden WE
    Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Int J Cardiol. 2023;373:39-43.
    PubMed     Abstract available

  13. PIERI K, Trichia E, Neville MJ, Taylor H, et al
    Polygenic risk in Type III hyperlipidaemia and risk of cardiovascular disease: An epidemiological study in UK Biobank and Oxford Biobank.
    Int J Cardiol. 2023;373:72-78.
    PubMed     Abstract available

  14. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    PubMed     Abstract available

  15. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    PubMed     Abstract available

    January 2023
  16. AHMED AI, Al Rifai M, Alahdab F, Saad JM, et al
    Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study.
    Int J Cardiol. 2023;371:465-471.
    PubMed     Abstract available

  17. PROENCA T, Pinto RA, Carvalho MM, Rocha A, et al
    Sex disparities and dyslipidemic control in a coronary rehabilitation program.
    Int J Cardiol. 2023;370:72-74.
    PubMed     Abstract available

  18. ZANNONI J, Guazzi M, Milani V, Bandera F, et al
    Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis.
    Int J Cardiol. 2023;370:402-404.
    PubMed     Abstract available

    November 2022
  19. YOON YH, Park GM, Lee JY, Lee JH, et al
    Relationship between sexual differences and cardiovascular risk factors in the prevalence of asymptomatic coronary disease.
    Int J Cardiol. 2022 Nov 19:S0167-5273(22)01709.
    PubMed     Abstract available

  20. ALMEIDA VR, Ostolin TLVDP, Gonze BB, de Almeida FR, et al
    Early flattening of the oxygen pulse during the cardiopulmonary exercise test in asymptomatic adults and its association with cardiovascular risk factors.
    Int J Cardiol. 2022;367:65-73.
    PubMed     Abstract available

    August 2022
  21. MOHAMED MG, Osman M, Kheiri B, Saleem M, et al
    Polypill for cardiovascular disease prevention: Systematic review and meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022;360:91-98.
    PubMed     Abstract available

    July 2022
  22. JAVAID A, Ahmed AI, Han Y, Al Rifai M, et al
    Incremental prognostic value of spect over CCTA.
    Int J Cardiol. 2022;358:120-127.
    PubMed     Abstract available

    April 2022
  23. CIARDULLO S, Cannistraci R, Mazzetti S, Mortara A, et al
    Twenty-year trends in heart failure among U.S. adults, 1999-2018: The growing impact of obesity and diabetes.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00578.
    PubMed     Abstract available

  24. ORBAN M, Dietl M, Dischl D, von Samson-Himmelstjerna P, et al
    Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomography.
    Int J Cardiol. 2022 Apr 18. pii: S0167-5273(22)00556.
    PubMed     Abstract available

  25. OH GC, Ko T, Kim JH, Lee MH, et al
    Estimation of low-density lipoprotein cholesterol levels using machine learning.
    Int J Cardiol. 2022;352:144-149.
    PubMed     Abstract available

    December 2021
  26. RIZOS CV, Skoumas I, Rallidis L, Skalidis E, et al
    LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments.
    Int J Cardiol. 2021;345:119-124.
    PubMed     Abstract available

    October 2021
  27. BOUISSET F, Deney A, Ferrieres J, Panagides V, et al
    Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay.
    Int J Cardiol. 2021 Oct 23. pii: S0167-5273(21)01574.
    PubMed     Abstract available

    August 2021
  28. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    PubMed     Abstract available

    May 2021
  29. OTTOSSON F, Emami Khoonsari P, Gerl MJ, Simons K, et al
    A plasma lipid signature predicts incident coronary artery disease.
    Int J Cardiol. 2021;331:249-254.
    PubMed     Abstract available

    January 2021
  30. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    PubMed     Abstract available

  31. HAN J, Bilgrami S, Ross S, Broadhead H, et al
    Real-world lipid lowering effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: A single-centre study.
    Int J Cardiol. 2021;322:240-244.

    October 2020
  32. ATHYROS VG, Stavropoulos K, Imprialos KP, Doumas M, et al
    Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world data.
    Int J Cardiol. 2020;316:240-241.

    December 2019
  33. STEWART LK, Beam DM, Casciani T, Cameron SJ, et al
    Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.
    Int J Cardiol. 2019 Dec 26. pii: S0167-5273(19)30431.
    PubMed     Abstract available

    November 2019
  34. BANDYOPADHYAY D, Chakraborty S, Amgai B, Patel N, et al
    Acute myocardial infarction in the young - National Trend Analysis with gender-based difference in outcomes.
    Int J Cardiol. 2019 Nov 12. pii: S0167-5273(19)33095.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.